Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia

Leukemia and Lymphoma

Volumn 49, Issue 9, 2008, Pages 1752-1761

  Prat, Cristina ^a,b,c   Sancho, Juan Manuel ^a   Dominguez, Josep ^a,b,c   Xicoy, Blanca ^a   Giménez, Montse ^a,b   Ferrá, Christelle ^c   Blanco, Silvia ^a,b,c   Lacoma, Alicia ^a,b   Ribera, Josep Maria ^c   Ausina, Vicenc ^a,b,c  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

C reactive protein; Infection; Interleukins; Neopterin; Neutropenia; Procalcitonin

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; NEOPTERIN; PROCALCITONIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIUM CULTURE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEBRILE NEUTROPENIA; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; STEM CELL TRANSPLANTATION;

ADULT; AGED; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; FEVER; HEMATOLOGIC NEOPLASMS; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; MYCOSES; NEOPTERIN; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS;

EID: 52349086138     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802258956     Document Type: Article

References (35)

1. Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E. Calandra, T. et al. (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis, 34, pp. 730-751.
2. Sudhoff, T., Giagounidis, A. and Karthaus, M. (2000) Serum and plasma parameters in clinical evaluation of neutropenic fever. Antibiot Chemother, 50, pp. 10-19.
3. Kern, W. V. (2006) Risk assessment and treatment of low-risk patients with febrile neutropenia. Clin Infect Dis, 42, pp. 533-540.
4. Yonemori, K., Kanda, Y., Yamamoto, R., Hamaki, T., Suguro, M. Chizuka, A. et al. (2001) Clinical value of serial measurement of serum C-reactive protein level in neutropenic patients. Leuk Lymphoma, 41, pp. 607-614.
5. Arber, C., Passweg, J. R., Fluckiger, U., Pless, M., Gregor, M. Tichelli, A. et al. (2000) C-reactive protein and fever in neutropenic patients. Scand J Infect Dis, 32, pp. 515-520.
6. Prat, C., Dominguez, J., Andreo, F., Blanco, S., Pallares, A. Cuchillo, F. et al. (2006) Procalcitonin and neopterin correlation with aetiology and severity of pneumonia. J Infect, 52, pp. 169-177.
7. Erten, N., Genc, S., Besisik, S. K., Saka, B., Karan, M. A. Tascioglu, C. et al. (2004) The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients. J Chin Med Assoc, 67, pp. 217-221.
8. Engel, A., Knoll, S., Kern, P. and Kern, W. V. (2005) Interleukin-8 serum levels at fever onset in patients with neutropenia predict early medical complications. Infection, 33, pp. 380-382.
9. Assicot, M., Gendrel, D., Carsin, H., Raymond, J., Guilbaud, J. Bohuon, C. et al. (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet, 341, pp. 515-518.
10. Oberhoffer, M., Stonans, I., Russwurm, S., Stonane, E., Vogelsang, H. Junker, U. et al. (1999) Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med, 134, pp. 49-55.
11. Monneret, G., Laroche, B. and Bienvenu, J. (1999) Procalcitonin is not produced by circulating blood cells. Infection, 27, pp. 34-35.
12. Marth, C., Weiss, G., Koza, A., Reibnegger, G., Daxenbichler, G. Zeimet, A. G. et al. (1994) Increased production of immune activation marker neopterin by colony-stimulating factors in gynecological cancer patients. Int J Cancer, 58, pp. 20-23.
13. Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J. Crokaert, F. et al. (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis, 34, pp. 7-14.
14. Muller, B., White, J. C., Nylen, E. S., Snider, R. H., Becker, K. L. Habener, J. F. et al. (2001) Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab, 86, pp. 396-404.
15. Engel, A., Steinbach, G., Kern, P. and Kern, W. V. (1999) Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8. Scand J Infect Dis, 31, pp. 185-189.
16. Fleischhack, G., Kambeck, I., Cipic, D., Hasan, C. and Bode, U. (2000) Procalcitonin in paediatric cancer patients: Its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II. Br J Haematol, 111, pp. 1093-1102.
17. Giamarellou, H., Giamarellos-Bourboulis, E. J., Repoussis, P., Galani, L. Anagnostopoulos, N. et al. (2004) Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: Experience from a multicentre study. Clin Microbiol Infect, 10, pp. 628-633.
18. Ruokonen, E., Nousiainen, T., Pulkki, K. and Takala, J. (1999) Procalcitonin concentrations in patients with neutropenic fever. Eur J Clin Microbiol Infect Dis, 18, pp. 283-285.
19. Prat, C., Dominguez, J., Rodrigo, C., Gimenez, M., Azuara, M. Jimenez, O. et al. (2003) Procalcitonin, C-reactive protein and leukocyte count in children with lower respiratory tract infection. Pediatr Infect Dis J, 22, pp. 963-968.
20. Talpaz, M., Rakhit, A., Rittweger, K., O'Brien, S., Cortes, J. Fettner, S. et al. (2005) Phase I evaluation of a 40-kDa branched-chain long-acting pegylated IFN-alpha-2a with and without cytarabine in patients with chronic myelogenous leukemia. Clin Cancer Res, 11, pp. 6247-6255.
21. Chiang, J., Gloff, C. A., Yoshizawa, C. N. and Williams, G. J. (1993) Pharmacokinetics of recombinant human interferon-beta ser in healthy volunteers and its effect on serum neopterin. Pharm Res, 10, pp. 567-572.
22. de Bont, E. S., Vellenga, E., Swaanenburg, J. and Kamps, W. (2000) Procalcitonin: A diagnostic marker of bacterial infection in neutropenic cancer patients with fever?. Infection, 28, pp. 398-400.
23. Abrahamsson, J., Pahlman, M. and Mellander, L. (1997) Interleukin 6, but not tumour necrosis factor-alpha, is a good predictor of severe infection in febrile neutropenic and non-neutropenic children with malignancy. Acta Paediatr, 86, pp. 1059-1064.
24. Lehrnbecher, T., Venzon, D., de Haas, M., Chanock, S. J. and Kuhl, J. (1999) Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia. Clin Infect Dis, 29, pp. 414-419.
25. Engervall, P., Andersson, B. and Bjorkholm, M. (1995) Clinical significance of serum cytokine patterns during start of fever in patients with neutropenia. Br J Haematol, 91, pp. 838-845.
26. Sabat, R., Hoflich, C., Docke, W. D., Oppert, M., Kern, F. Windrich, B. et al. (2001) Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies. Intensive Care Med, 27, pp. 987-991.
27. Klastersky, J., Paesmans, M., Rubenstein, E., Boyer, M., Elting, L. Feld, R. et al. (2000) The multinational association for supportive care in cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol, 18, pp. 3038-3051.
28. Meisner, M. (2005) Biomarkers of sepsis: Clinically useful?. Curr Opin Crit Care, 11, pp. 473-480.
29. Persson, L., Soderquist, B., Engervall, P., Vikerfors, T., Hansson, L. O. Tidefelt, U. et al. (2005) Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia. Eur J Haematol, 74, pp. 297-303.
30. von Lilienfeld-Toal, M., Schneider, A., Orlopp, K., Hahn-Ast, C., Glasmacher, A. Stuber, F. et al. (2006) Change of procalcitonin predicts clinical outcome of febrile episodes in patients with hematological malignancies. Support Care Cancer, 14, pp. 1241-1245.
31. Ortega, M., Rovira, M., Filella, X., Almela, M., Puig de la, J Bellacasa Carreras, E. et al. (2004) Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation. Br J Haematol, 126, pp. 372-376.
32. Christofilopoulou, S., Charvalos, E. and Petrikkos, G. (2002) Could procalcitonin be a predictive biological marker in systemic fungal infections? Study of 14 cases. Eur J Intern Med, 13, pp. 493-495.
33. Dornbusch, H. J., Strenger, V., Kerbl, R., Lackner, H., Schwinger, W. Sovinz, P. et al. (2003) Procalcitonin and C-reactive protein do not discriminate between febrile reaction to anti-T-lymphocyte antibodies and gram-negative sepsis. Bone Marrow Transplant, 32, pp. 941-945.
34. Ortega, M., Rovira, M., Filella, X., Martinez, J., Almela, M. Puig, J. et al. (2006) Prospective evaluation of procalcitonin in adults with non-neutropenic fever after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant, 37, pp. 499-502.
35. Dornbusch, H. J., Strenger, V., Kerbl, R., Lackner, H., Schwinger, W. Sovinz, P. et al. (2003) Procalcitonin and C-reactive protein do not discriminate between febrile reaction to anti-T-lymphocyte antibodies and gram-negative sepsis. Bone Marrow Transplant, 32, pp. 941-945.